1. Home
  2. AMLX vs MIN Comparison

AMLX vs MIN Comparison

Compare AMLX & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMLX
  • MIN
  • Stock Information
  • Founded
  • AMLX 2014
  • MIN 1988
  • Country
  • AMLX United States
  • MIN United States
  • Employees
  • AMLX N/A
  • MIN N/A
  • Industry
  • AMLX Biotechnology: Pharmaceutical Preparations
  • MIN Trusts Except Educational Religious and Charitable
  • Sector
  • AMLX Health Care
  • MIN Finance
  • Exchange
  • AMLX Nasdaq
  • MIN Nasdaq
  • Market Cap
  • AMLX 330.5M
  • MIN 306.1M
  • IPO Year
  • AMLX 2022
  • MIN N/A
  • Fundamental
  • Price
  • AMLX $3.56
  • MIN $2.70
  • Analyst Decision
  • AMLX Buy
  • MIN
  • Analyst Count
  • AMLX 4
  • MIN 0
  • Target Price
  • AMLX $7.50
  • MIN N/A
  • AVG Volume (30 Days)
  • AMLX 789.6K
  • MIN 331.0K
  • Earning Date
  • AMLX 05-08-2025
  • MIN 01-01-0001
  • Dividend Yield
  • AMLX N/A
  • MIN 7.31%
  • EPS Growth
  • AMLX N/A
  • MIN N/A
  • EPS
  • AMLX N/A
  • MIN 0.08
  • Revenue
  • AMLX $87,371,000.00
  • MIN N/A
  • Revenue This Year
  • AMLX N/A
  • MIN N/A
  • Revenue Next Year
  • AMLX N/A
  • MIN N/A
  • P/E Ratio
  • AMLX N/A
  • MIN $33.38
  • Revenue Growth
  • AMLX N/A
  • MIN N/A
  • 52 Week Low
  • AMLX $1.58
  • MIN $2.52
  • 52 Week High
  • AMLX $7.27
  • MIN $2.88
  • Technical
  • Relative Strength Index (RSI)
  • AMLX 51.34
  • MIN 51.19
  • Support Level
  • AMLX $3.23
  • MIN $2.68
  • Resistance Level
  • AMLX $3.83
  • MIN $2.73
  • Average True Range (ATR)
  • AMLX 0.26
  • MIN 0.02
  • MACD
  • AMLX -0.01
  • MIN 0.00
  • Stochastic Oscillator
  • AMLX 58.27
  • MIN 50.00

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

About MIN MFS Intermediate Income Trust

MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.

Share on Social Networks: